Page last updated: 2024-10-24

celecoxib and Germinoblastoma

celecoxib has been researched along with Germinoblastoma in 3 studies

Research Excerpts

ExcerptRelevanceReference
"Inhibition of cyclooxygenase 2 (COX-2) by the selective COX-2 inhibitor celecoxib has been suggested as potentially useful for B-cell lymphoma therapy."7.76Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2. ( Chen, ST; Gaffney, KJ; Louie, SG; Petasis, NA; Schönthal, AH; Thomas, S, 2010)
"Inhibition of cyclooxygenase 2 (COX-2) by the selective COX-2 inhibitor celecoxib has been suggested as potentially useful for B-cell lymphoma therapy."3.76Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2. ( Chen, ST; Gaffney, KJ; Louie, SG; Petasis, NA; Schönthal, AH; Thomas, S, 2010)
"Celecoxib abrogated carrageenan-induced hyperalgesia in the hind paw accompanied by a decrease in PGE2 content in paw exudates and cerebrospinal fluid in a dose-related manner, with an ED30 = 0."1.33Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. ( Fukunaga, M; Hayashi, A; Kimoto, A; Kobayashi, S; Miyata, K; Noguchi, M; Sasamata, M; Yoshino, T, 2005)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, ST1
Thomas, S1
Gaffney, KJ1
Louie, SG1
Petasis, NA1
Schönthal, AH1
Yoshino, T1
Kimoto, A1
Kobayashi, S1
Noguchi, M1
Fukunaga, M1
Hayashi, A1
Miyata, K1
Sasamata, M1
Ramos, J1
Sirisawad, M1
Miller, R1
Naumovski, L1

Other Studies

3 other studies available for celecoxib and Germinoblastoma

ArticleYear
Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2.
    Leukemia research, 2010, Volume: 34, Issue:2

    Topics: Boronic Acids; Bortezomib; Celecoxib; Cell Death; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase

2010
Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
    Arzneimittel-Forschung, 2005, Volume: 55, Issue:7

    Topics: Animals; Carrageenan; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cy

2005
Motexafin gadolinium modulates levels of phosphorylated Akt and synergizes with inhibitors of Akt phosphorylation.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Celecoxib; Cell Line, Tumor; Cyclooxygenase Inhibitors; Docetaxel;

2006